Osterloh Anke
Research Center Borstel, Parkallee 22, 23845 Borstel, Germany.
Vaccines (Basel). 2021 Aug 12;9(8):896. doi: 10.3390/vaccines9080896.
Rickettsioses are febrile, potentially lethal infectious diseases that are a serious health threat, especially in poor income countries. The causative agents are small obligate intracellular bacteria, rickettsiae. Rickettsial infections are emerging worldwide with increasing incidence and geographic distribution. Nonetheless, these infections are clearly underdiagnosed because methods of diagnosis are still limited and often not available. Another problem is that the bacteria respond to only a few antibiotics, so delayed or wrong antibiotic treatment often leads to a more severe outcome of the disease. In addition to that, the development of antibiotic resistance is a serious threat because alternative antibiotics are missing. For these reasons, prophylactic vaccines against rickettsiae are urgently needed. In the past years, knowledge about protective immunity against rickettsiae and immunogenic determinants has been increasing and provides a basis for vaccine development against these bacterial pathogens. This review provides an overview of experimental vaccination approaches against rickettsial infections and perspectives on vaccination strategies.
立克次体病是一类发热性、具有潜在致命性的传染病,对健康构成严重威胁,在低收入国家尤为如此。其病原体是一类小型专性细胞内细菌,即立克次体。立克次体感染在全球范围内不断出现,发病率和地理分布都在增加。然而,这些感染显然存在诊断不足的情况,因为诊断方法仍然有限且往往难以获得。另一个问题是,这些细菌仅对少数几种抗生素有反应,因此抗生素治疗延迟或错误往往会导致疾病的后果更为严重。除此之外,抗生素耐药性的出现是一个严重威胁,因为缺乏替代抗生素。基于这些原因,迫切需要针对立克次体的预防性疫苗。在过去几年中,关于抗立克次体保护性免疫和免疫原性决定因素的知识不断增加,为针对这些细菌病原体的疫苗开发提供了基础。本综述概述了针对立克次体感染的实验性疫苗接种方法以及疫苗接种策略的前景。